Dr. Vandana Agarwal, MD

Dr. Agarwal practices at Los Angeles Cancer Network in Glendale, California.

Dr. Agarwal's NPI, 1134124548, was assigned on June 14, 2005. Dr. Agarwal graduated from Gandhi Medical College in 1981. Dr. Agarwal holds California license A41760.

Dr. Agarwal's primary practice is Los Angeles Cancer Network, at 541 W Colorado St, Glendale, CA 91204 in Los Angeles County. The practice phone is (213) 977-1214.

Dr. Agarwal's primary practice is Los Angeles Cancer Network in Glendale, California. The medical group on file is Los Angeles Cancer Network. Dmand AI also links Dr. Agarwal to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Agarwal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Agarwal's licenses on file in 10 states: California, Florida, Nevada, Texas, Arizona, Hawaii, Kentucky, Mississippi, Oklahoma and Oregon.

Dmand AI lists chronic anemia, chronic leukemia, colorectal cancer, lung cancer, neutropenia, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Agarwal treats.

CMS data shows 493 Medicare services from Dr. Agarwal across 4 procedure codes in 2024, for 59 Medicare patients. Medicare paid $49,994 for them. Every service was in an office.

CMS counts 59 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 76% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 59, with 62% women.

In 2024, Dr. Agarwal wrote 1,376 Medicare Part D claims for 158 patients. 81% of them were for generic drugs. CMS names the drug for 968 of them, across 33 drugs with 11 or more claims each, at $1,270,126 in total drug cost. In 2023, CMS named 1,351 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Agarwal for performance year 2024, reported individually. Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agarwal as offering telehealth.

Dmand AI links 5 papers to Dr. Agarwal, published from 2013 to 2025. 2021 was the busiest year, with 2. The most frequent topics are India. Dr. Agarwal's most frequent co-authors are Kanika Agarwal, MD, Mandeep S. Bakshi, MD and Nikesh N. Shah, MD.

CMS Open Payments shows 1,425 general payments to Dr. Agarwal from 88 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Novartis Pharmaceuticals Corporation paid the most, $25,166.

Dmand AI lists 3 awards for Dr. Agarwal, most recently Top Doctors:LA Area in 2013.

Dr. Agarwal graduated from Gandhi Medical College in 1981. Dr. Agarwal is a member of ACP and ASCO.

Dr. Agarwal is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.